You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Velcade-melphalan-prednisone

Showing 1551 - 1575 of 1,641
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial (Holmium-166-DOTMP)

Terminated
  • Multiple Myeloma
  • (no location specified)
Jan 19, 2009

Neuroblastoma, CNS Tumors, Lymphomas Trial in Memphis (Stem Cell Transplantation, Busulfan, Melphalan)

Completed
  • Neuroblastoma
  • +3 more
  • Stem Cell Transplantation
  • Busulfan, Melphalan
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Feb 12, 2009

Multiple Myeloma Trial in United States (ATN-224 + bortezomib)

Terminated
  • Multiple Myeloma
  • ATN-224 + bortezomib
  • Fresno, California
  • +9 more
Oct 27, 2008

Leukemia Trial in Bologna (Bortezomib)

Completed
  • Leukemia
  • Bologna, Italy
    Policlinico "S.Orsola-Malpighi"-Istituto di Ematologia "L e A Se
Nov 21, 2008

T-Cell Lymphoma, Lymphoma, Non-Hodgkin's Trial in New York (CHOP and alemtuzumab)

Completed
  • T-Cell Lymphoma
  • Lymphoma, Non-Hodgkin's
  • CHOP and alemtuzumab
  • New York, New York
    Weill Medical College of Cornell University
Oct 21, 2008

IGA Glomerulonephritis Trial (omega-3 fatty acids, prednisone)

Completed
  • IGA Glomerulonephritis
  • (no location specified)
Sep 8, 2008

Prostate Cancer Trial in Worldwide (Immunotherapy with allogeneic prostate vaccine, Chemotherapy (Taxotere and prednisone))

Terminated
  • Prostate Cancer
  • Immunotherapy with allogeneic prostate vaccine
  • Chemotherapy (Taxotere and prednisone)
  • Alabaster, Alabama
  • +125 more
Nov 3, 2008

Prostate Cancer Trial in Worldwide (Immunotherapy allogeneic GM-CSF secreting cellular vaccine, Chemotherapy (docetaxel and

Terminated
  • Prostate Cancer
  • Immunotherapy allogeneic GM-CSF secreting cellular vaccine
  • Chemotherapy (docetaxel and prednisone)
  • Anchorage, Alaska
  • +114 more
Sep 19, 2008

Primary Gastric Diffuse-Large B-Cell Lymphoma Trial in Germany (Rituximab + CHOP chemo)

Completed
  • Primary Gastric Diffuse-Large B-Cell Lymphoma
  • Rituximab + CHOP chemotherapy
  • Augsburg, Germany
  • +4 more
Oct 17, 2008

Wegener's Granulomatosis, Churg-Strauss Syndrome, Microscopic Polyangiitis Trial in Parma (Methotrexate, Cyclophosphamide)

Unknown status
  • Wegener's Granulomatosis
  • +3 more
  • Parma, Italy/Parma, Italy
    Department of Clinical Medicine Nephrology and Health Science, P
Sep 11, 2008

Tumors, Non-Hodgkins's Lymphoma Trial in Dallas (omeprazole and bortezomib)

Completed
  • Tumors
  • Non-Hodgkins's Lymphoma
  • omeprazole and bortezomib
  • Dallas, Texas
    Mary Crowley Medical Research Center
Jun 4, 2008

Hodgkin Disease Trial in Cologne (Bortezomib, Dexamethasone)

Terminated
  • Hodgkin Disease
  • Cologne, NRW, Germany
    University of Cologne
Jul 9, 2008

Amyloidosis Trial in New York (Melphalan, Autologous Stem Cell Transplantation)

Completed
  • Amyloidosis
  • New York, New York
    Herbert Irving Comprehensive Cancer Center
Jun 6, 2008

Kidney Transplantation Trial (Cyclosporine, CP-690-,550)

Withdrawn
  • Kidney Transplantation
  • (no location specified)
May 27, 2008

NSCLC Trial in Haine-Saint-Paul (VELCADE, Alimta)

Completed
  • Non-Small Cell Lung Cancer
  • Haine-Saint-Paul, Belgium
    Hopital de Jolimont
Mar 11, 2008

Myasthenia Gravis, Generalized Trial in Worldwide (mycophenolate mofetil (CellCept), )

Completed
  • Myasthenia Gravis, Generalized
  • mycophenolate mofetil (CellCept)
  • placebo
  • Sun City, Arizona
  • +42 more
May 23, 2008

Myasthenia Gravis Generalised Trial in Worldwide (mycophenolate mofetil [CellCept], Placebo)

Completed
  • Myasthenia Gravis Generalised
  • mycophenolate mofetil [CellCept]
  • Placebo
  • Sun City, Arizona
  • +15 more
May 22, 2008

Myelodysplastic Syndrome Trial in Boston (bortezomib)

Terminated
  • Myelodysplastic Syndrome
  • Boston, Massachusetts
  • +2 more
Mar 7, 2008

Melanoma, Sarcoma Trial run by the NCI (double isolated limb perfusion with melphalan alone)

Completed
  • Melanoma
  • Sarcoma
  • double isolated limb perfusion with melphalan alone
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Colorectal Carcinoma Trial in United States (VELCADE TM (bortezomib) for Injection, or PS-341)

Completed
  • Colorectal Carcinoma
  • VELCADE TM (bortezomib) for Injection, or PS-341
  • Birmingham, Alabama
  • +21 more
Feb 7, 2008

NSCLC Trial in United States (VELCADE™ (bortezomib) for Injection (formerly PS-341))

Completed
  • Non-Small Cell Lung Cancer
  • VELCADE™ (bortezomib) for Injection (formerly PS-341)
  • Birmingham, Alabama
  • +19 more
Feb 7, 2008

B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)

Completed
  • B-Cell Lymphoma
  • +2 more
  • VELCADE and rituximab
  • Los Angeles, California
  • +12 more
Feb 7, 2008

DLBCL, POOR PROGNOSIS Trial in Italy (drug, radiation, procedure)

Completed
  • Diffuse Large B-Cell Lymphoma
  • POOR PROGNOSIS
  • Alessandria, Italy
  • +13 more
Nov 8, 2007

Mantle Cell Lymphoma Trial in United States (VELCADE TM (bortezomib) for Injection)

Completed
  • Mantle Cell Lymphoma
  • VELCADE TM (bortezomib) for Injection
  • Birmingham, Alabama
  • +34 more
Feb 7, 2008

Prostatic Tumors Trial in United States (VELCADE TM (bortezomib) for Injection)

Completed
  • Prostatic Neoplasms
  • VELCADE TM (bortezomib) for Injection
  • Los Angeles, California
  • +3 more
Feb 7, 2008